Rezolute, Inc. (RZLT) Form 8-K — May 12, 2026
Rezolute, Inc. reported its financial results for the third quarter ended March 31, 2026. The company's cash, cash equivalents, and investments in marketable securities were $120.3 million as of March 31, 2026, down from $167.9 million as of June 30, 2025. Research and development expenses decreased to $11.4 million for the third quarter of fiscal 2026, compared with $15.3 million for the same period a year ago.
Key figures
- Eps
- -0.16
- Eps Beat
- 0
- Revenue
- 0
- Net Income
- -16,171
- Total Debt
- 0
- Debt Amount
- 0
- Revenue Yoy
- 0
- Total Assets
- 125,459
- Cash Position
- 11,236
- Deal Value Usd
- 0
- Interest Rate
- 0
- Gross Proceeds
- 0
- Offering Price
- 0
- Shares Offered
- 0
- Shares Outstanding
- 104,040
- Working Capital
- 114,345
- Accumulated Deficit
- -460,951
- Cash And Cash Equivalents
- 11,236
- Total Stockholders Equity
- 116,834
- Investments In Marketable Debt Securities
- 109,032
Price after filing
1 day: +0.9%7 days: -6.1%30 days: +15.5%
Close on the filing date to close N calendar days later (from $3.30). Historical, not a forecast.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.